| For: | Manoubi W, Mahdouani M, Hmida D, Kdissa A, Rouissi A, Turki I, Gueddiche N, Soyah N, Saad A, Bouwkamp C, Elgersma Y, Mougou-Zerelli S, Gribaa M. Genetic investigation of the ubiquitin-protein ligase E3A gene as putative target in Angelman syndrome. World J Clin Cases 2024; 12(3): 503-516 [PMID: 38322471 DOI: 10.12998/wjcc.v12.i3.503] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v12/i3/503.htm |
| Number | Citing Articles |
| 1 |
Ayesha Sana Soomro, Afifa Javed, Arleen Yousuf, Abdul Sattar Qureshi, Imrana Khushk. The Emerging Role of <i>In Silico</i> Approaches in Understanding UBE3A and Its Neurological Implications. BioMed Target Journal 2025; 3(2) doi: 10.59786/bmtj.321
|
| 2 |
Jacqueline Fátima Martins de Almeida, Ilaria Tonazzini, Simona Daniele. Molecular aspects of Angelman Syndrome: Defining the new path forward. Biomolecules and Biomedicine 2025; 25(9) doi: 10.17305/bb.2025.11724
|
| 3 |
Mirella Vinci, Simone Treccarichi, Rosanna Galati Rando, Antonino Musumeci, Valeria Todaro, Concetta Federico, Salvatore Saccone, Maurizio Elia, Francesco Calì. A de novo ARIH2 gene mutation was detected in a patient with autism spectrum disorders and intellectual disability. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-66475-2
|